- Study from the Netherlands explores physicians' caution towards AI-based skin cancer assessment apps.
- Concerns include misdiagnosis, patient exclusion, and clinical care disruption.
- Potential benefits recognized, with emphasis on requirements for accuracy, integration, and accessibility.
- GPs concerned about losing clinical autonomy and increased unnecessary referrals.
- Endorsement conditions involve accurate testing, seamless integration, and accessibility to diverse users.
Source: BMC
